chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Anxiety; Headache; Soreness at  injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), HEADACHE (Headache), INJECTION SITE PAIN (Soreness at  injection site) and FATIGUE (Fatigue) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced HEADACHE (Headache), INJECTION SITE PAIN (Soreness at  injection site) and FATIGUE (Fatigue). On 19-Feb-2021, the patient experienced ANXIETY (Anxiety). At the time of the report, ANXIETY (Anxiety) outcome was unknown and HEADACHE (Headache), INJECTION SITE PAIN (Soreness at  injection site) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not reported  Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded.
Fever, nausea, abdominal pain, weakness in lower left leg, extremely sore arm, severe fatigue, flu like symtpoms
Extreme fatigue, swollen glands, swollen lymph nodes under arms, fever, and very cranky.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE PULMONARY EMBOLISM
Irregular, very heavy  period began 1-2 days after receiving 2nd dose of covid vaccine on May 1st
Swelling, redness, rash arm pain for 10 days. Antibiotic for (Cephalexin 500mg) 1 week.
17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (17 patients may have received a Moderna bivalent booster dose of 0.25ml instead of 0.5ml).    No concomitant medications were provided. No treatment medication was provided. This case contains information for the 14th out of 17 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-707980 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-707980:Case for patient
This spontaneous report was received from a nurse practitioner regarding a currently 22 years old non-pregnant female patient. Information on pertinent medical history, drug reactions/allergies and concomitant medications were not reported. The patient was vaccinated with GARDASIL, dose 1 on an unknown date in November 2009, dose 2 on an unknown date in January 2010 and a 3rd dose on an unknown date in April 2010. On 20-DEC-2016, the patient was seen in office for a colposcopy for an abnormal pap smear/ atypical cells. No treatment was given for the event. The patient sought medical attention by visiting the office. Patient's present status was reported as "doing fine". Causality of the event was not reported. No product quality complaint was involved. Additional information has been requested.
On 3/5 I began with a  headache and nausea, with escalating chills which by 2:30 PM included a high temperature of 102.  I had severe muscular and joint pain.  Could not get out of bed.  Was able to get assistance from a local nurse who pushed a mixture of cranberry juice and water, crackers to help nausea, and use of cool wet washclothes to help lower temperature.  I was also given extra strength tylenol.  My husband was about ready to call ambulance for trip to ER when temperature began to drop and I was able to relax, falling asleep.  By 12:30 AM severity of pains and temperature abated.  On 3/5 left arm began showing signs of "covid arm" with severe itching.  Benedryl cream helped with itching.  By 3/9 "covid arm" disappeared.  However, I am extremely weak from the ordeal and tire easily.  The nausea is still present but not as bad.  A diet high in probiotics has helped.
pt recv vax 31MAR98 & w/in 24hr began to have redness/tenderness approx 3" diameter @ site;no other sx;
Client stated he received a Tdap vaccine on 6-1-15 at his PMD's office, and 2 days later he experienced weakness, loss of appetite, weight loss, soreness and redness that radiated from his (L) arm (site of injection) to (L) shoulder, (L) side lower neck, (L) side of chest, behind (L) ear.
The patient complains of stiff neck, swelling under the arm that was injected, and a "stinging" type sensation down her arm. No treatment has been sought by the patient.
30JAN97 8PM pt started feeling warm was cranky;awoke 31JAN97 w/temp 100.5, cranky, tired this progressed to a temp of 102.5;lethargy, & crankiness Friday p/noon;c/o nausea, threw up 31JAN97 evening;tired, cranky t101 until 2FEB97
16 days after the shot, large red patch resembling a bullseye appeared at injection site. No itching so far. Have had other problems but they have been attributed to cancer medication or cancer itself. Have also developed a slight cough and congestion the last week
booster doses (1 to each patient) to 2 patients who were less than then age of 18 years.; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (booster doses (1 to each patient) to 2 patients who were less than then age of 18 years.) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. On 22-Nov-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (booster doses (1 to each patient) to 2 patients who were less than then age of 18 years.). On 22-Nov-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (booster doses (1 to each patient) to 2 patients who were less than then age of 18 years.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported.  No treatment information was provided.  Reporter has stated that to her knowledge this was the only dose the patients received.
Intermittent palpitations on 11/2/2021 followed by chest pain/discomfort on inspiration on 11/3/2021. Increased water intake and rested.
Patient complained of a very painful arm that resulted him having limited arm motion by that evening. He complained of lots of pain at night when trying to lay on that side. Patient followed up with dr 12/3/18 and was given a medrol dosepack. Patient stated pain went away and motion was almost back to normal. After stopping the dosepack, the pain returned and motion deccreased. Patient went back to doctor 12/12 and he prescribed another dosepack (based on profile). Unware of next steps doctor is taking. Also unware if injury/symptoms directly related to shot. When spoke with office they said they were going to try a steriod pack, and if that did not work the patient would follow up in office.
HEADACHE; FATIGUE; FEVER; MUSCLE ACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers . No concomitant medications were reported. On an unspecified date, the subject experienced headache, fatigue, fever, and muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, fatigue, fever and muscle ache was not reported. This report was non-serious.
Arm swollen, warm, red and firm to touch from right shoulder down to right elbow.
The day after receiving the vaccines at night, dad noticed redness, swelling of leg, looks like allergic reaction.  Patient went emergency room. No fever.
Hives and Rashes all over entire body 10 days after Moderna booster. Chest tightness and difficulty breathing.
Patient reported dizziness and numbness in lower arm. The symptoms started very soon after injection and persisted for over an hour. He then reported the dizziness had subsided and he developed a headache. The numbness in his arm continued. He was given water, ice pack, and tylenol while at the pharmacy. He felt well enough to go home with his father, but too ill to drive. He did not require emergency treatment.
Information has been received from a nurse concerning an elderly pt who was vaccinated SC with a dose of Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). Subsequently, the pt developed a hugh rash and swelling at the injection site. Medical attention was sought. Subsequently, the pt recovered. The nurse requested that a lot check be preformed. The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. In addition, a review of the system revealed that there were no open Quarantines registered against this lot/fill. Additional information has been requested.
Pt. given vaccine, returned 10 minutes later complaining of shortness of breath, fatigue, and chills. Call 911 per pt. to received treatment. After evaluation, paramedics feel it was anxiety that could have caused such a reaction.
muscle pain; unable to sleep; tendonitis; fever; shoulder pain; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on 22Feb2021 as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 for COVID-19 immunization received on 22Jan2021. It was reported that, Patient is male, aged 72, received first Pfizer vaccine on 22Jan2021 and his second Pfizer vaccine on 22Feb2021. He developed very bad muscle pain in the arm muscle where he was injected. He says at night it reaches a 9 out of 10 on the pain scale. He is unable to sleep. He went to the doctor and he said it may be tendonitis. He also experienced a mild 99 degree fever and a little shoulder pain. Patient was asking are these common side effects of the vaccine and Dr prescribed Medrol dose pack for patient, is this okay to take right after receiving second vaccine. The patient underwent lab tests and procedures which included FEVER (body temperature): mild 99 degree fever on an unspecified date, pain scale (pain assessment): 9 out of 10 on an unspecified date. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Narrative:  Fully vaccinated, admitted for agitation/irritability on 6/23 found to be COVID positive on 7/6 when tested for SNF placement
Booster dose. Vaccine administered on 10/29/21. Vial expired 10/11/21. Vial was kept in freezer until 10/28/2021 and removed to fridge on 10/28/2021 for administration on 10/29/2021.
(8/25/2021) Ocular Migraine, no treatment, asked to come back if issue reoccurs. Improved since scan.
Patient felt a little light headed/dizzy. then immediately vomited. Once she had vomited she immediately felt better but sick to her stomach.
At about six weeks pregancy, my doctor's office recommended that I get the H1N1 vaccine. So I did on/about 12/09/2009. Three days later, I started bleeding. I bled steadily for one month. I had repeated ultrasounds and was told there was no problem. During a CVS at about 16 weeks, I was told that it seemed that my son had a cerebellar abnormality. I was forced to terminate the pregnancy. It was found that I had a placental blood clot that measured 7cm. I have since corresponded with another woman who had the exact same history with regard to the vaccine and her pregnancy; which she had to terminate.
Pt. received Varicella vac. 8/30/11. The next day had redness & swelling & tender at site. Seen by Dr. 9/1/11 8-10 cm erythematous area with warmth & induration.
Patient was given pediatric covid vaccine (5-11 years old) and patient is 12 years old. Patient should have received adult Pfizer vaccine. Patient did not have a reaction in the clinic and is doing well the next day (5/25/22). Mother was notified.
12/5 admission 12/6 picc removed midline placed 12/9 FEES mild oropharyngeal dysphagia- cleared for puree 12/10 Cardiac arrest, intubation, septic shock  12/10 CXR bilateral infiltrates small effusions 12/11 +BCX MRSE 1of2 probable contaminant 12/14  Renal US - no hydronephrosis  12/20 BCX + MRSE 1 of 2  12/22 B CX no growth to date 12/22 Tracheostomy  1/4  Recurrent hypotension, possible sepsis, resumed pressors, goals of care DNR 1/4 CXR worsened right pleural effusion 1/8  proceed with comfort care
Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/26/2023 Discharge Date: Mar 29, 2023  PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] Constipation, unspecified constipation type [K59.00]   HOSPITAL COURSE:  83 y.o. male with past medical history significant for  panhypopituitarism, dyslipidemia, anxiety and depression, hypertension, GERD, hypothyroidism who presented with complaints of generalized weakness, recurrent falls.  Previously living with wife who felt she could no longer care for him.  Fall on morning of presentation.  Patient admitted for further care.   Reviewing chart, patient has been seen for multiple visits in the movement Disorders Clinic.  Possible diagnosis of Parkinson's disease however testing returned intermediate on imaging.  Patient with noted lower extremity weakness.  In movement Disorder Clinic had been offered repeat electromyogram to better determine etiology and at that time patient refused.  PT/OT evaluated patient and recommended skilled nursing facility.  Patient has also been followed by Urology in the outpatient setting.  Noted urinary retention BPH and urinary urgency.  Patient initially cathed with 1 L urine removed.  Continue to require intermittent straight catheterization.  Urology consulted and recommended: Have pt up to void every 3-5 hours.  1. If the patients voids check bladder scan as PVR and if PVR greater than the amount voided, then st. Cath.  2. If the patient does not void, check bladder scan and if scan is greater than 350 ml, then st. Cath.   Try to keep total bladder volume (void + cath) less than 500 ml (between 350 and 500 ml).  If it is more than 500 ml, perform above more frequently. Follow-up in clinic.  Screening COVID test returned positive however patient had had recent COVID-19 infection at the beginning of the month that had resolved.     Patient strongly desires to return home and feels that he is able to manage at home with help of wife and walker unfortunately as family is unable to care for patient will be transferred to skilled nursing.  Consider returned to movement Disorders Clinic for rediscussion on electromyogram to determine if results would lead to any meaningful intervention.     Also noted patient has a baseline diagnosis of dysphagia and will be discharged on a dysphagia diet.
Patient and parent came in for patient?s 4 Month physical and vaccines.  Patient was inadvertently given an expired dose of Pentacel, which is a combination of Dtap, IPV, and HIB.   The expiration date was 3/12/2022. Other vaccines given were Prevnar (PCV) and Rota Virus (RotaTeq), which were both current.
Felt like arm is asleep, headache, chills, weakness, dizzy, nausea, vomiting, diarrhea  and very tired.
101 temperature with severe flu like symptons - body aches, tiredness. Flu symptons disapated on the 7th  and was followed by a severe body rash that showed up on the 8th(torso, arms,, neck, mouth, throat)
COVID-19; This is a spontaneous report received from a Pfizer sponsored program, via a contactable consumer. A 91-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 19Mar2021 at single dose (at 91-year-old) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 23Mar2021, patient tested positive to COVID-19 virus and experienced fever. 2nd dose would be on 10Apr2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
No adverse events, no treatment required. Increased monitoring done. Vaccine not indicated in this age group.
10/09/2022  Started as a sore throat. The next day I did not feel well. My sore throat was more severe with head cold and congestion. I tested negative twice on 10/10/22. 10/11/22 I had chills, brain fog, exhaustion, very nauseous and congestion in my chest.  in addition to what I had the day before.  I tested negative for COVID. 10/12/22 I tested Positive for COVID and had the same symptoms. By 10/13/22 the sore throat was gone, it was only the congestion, head cold, brain fog, exhaustion and nausea. I had a tele visit with my doctor on 10/13/22.   She prescribed medicine for the congestion and nausea. Told me to continue what I am doing. She informed me of the CDC guidelines.   10/14-10/15 was brain fog, congestion, exhaustion, a bad headache, and head cold. 10/16/2022 I still had congestion and head cold.  Today I just have nasal congestion, but not as bad as it has been.
Pt. has rash on upper torso/chest area and back of neck. Rash started 5/1/12 1 day after injection given. No treatment given to pt. at this time.
Patient has reported petechiae rash on right arm from administration side to roughly elbow.  Patient has also reported newly elevated blood pressure. Currently being treated with prednisone, benadryl, and lisinopril
Pt received dose of vaccine on Sunday. Had business trip on Thursday. After flight became short of breath and had discomfort in the chest. Worsening on trip back
Heart pain, tiredness, dizziness. I had a stress test and have scheduled a CT scan of the heart for July 17.
severe pain in my right leg from mid thigh to lower ankle- feels like someone is crushing the bones in my leg/comes on instantly with various movements; severe pain in my right leg from mid thigh to lower ankle- feels like someone is crushing the bones in my leg/comes on instantly with various movements; severe pain in my right leg from mid thigh to lower ankle- feels like someone is crushing the bones in my leg/comes on instantly with various movements; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE), dose 2 via an unspecified route of administration in the left arm on 04Apr2021 15:00 (Lot Number: ER8730) as a single dose for covid-19 immunisation. Medical history included major depressive disorder and (CVID) common variable immunodeficiency. The patient has no known allergies. The patient was not diagnosed with Covid-19 prior to vaccinationThe patient received the first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE) on 14Mar2021 at 15:00 (lot number: EN6202) in the left arm at vaccination age 46-year-old for covid-19 immunization. Concomitant medications included fluoxetine hydrochloride (PROZAC), lamotrigine (LAMICTAL), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), valacyclovir [valaciclovir] (VALACYCLOVIR), cyanocobalamin (B-12), and gam; all indication, start and stop date were not reported. The patient did not receive other vaccine in four weeks. The patient received the vaccine in a pharmacy or drug store. It was reported that 6 days later (05Apr2021 10:30 AM), she had severe pain in her right leg from mid-thigh to lower ankle. She feels like someone is crushing the bones in her leg (comes on instantly with various movements), has 9-10 on a pain scale of 0-10 and 98% of time can no longer bend her leg when sitting on ground or pain is unbearable. The adverse event resulted in emergency room/department or urgent care for the disability or permanent damage. The events received treatment which included wrapped knee and was referred to an orthopedic doctor. The patient has not been tested post vaccination. The outcome of the events was not recovered.
I have had Diarrhea Ever since; everything I eat I go straight to go loo.; This is a spontaneous report from a contactable consumer (patient).   A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 17Aug2021 (at the age 62-years-old) as dose 1, single for covid-19 immunization.  Medical history included type 2 diabetes mellitus, blood cholesterol, slow blood flow and high blood. The patient's concomitant medications were not reported. Prior to vaccination, the patient did not receive any other vaccines. On Tuesday (17Aug2021) after the first dose of vaccine patient was having diarrhea. Patient reported everything she eats go straight to loo. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient presented for J&J Covid-19 Vaccination. Reported feeling anxious in anticipation of vaccination and stated that she felt like her heart was racing. Patient denies chest pain, shortness of breath or any other s/s. Assisted patient to wheelchair for safety and monitoring.  11:40 BP 137/90, p=132 regular, rr=18/min, o2 sat 98%RA.  11:45 BP 127/83, p=116 regular , rr= 18/min, o2sat 98%RA. Patient denies chest pain, shortness of breath or any other s/s.  11:52 BP 131/86, p=124 regular, rr=18/min, o2sat 96%RA. Patient denies chest pain, shortness of breath or any other s/s.  12:08 BP 115/80, p=96 regular, rr=18/min, o2sat 97%RA. Patient denies chest pain, shortness of breath or any other s/s.  12:20 BP 126/84, p=105, rr/16/min, o2sat 98%RA. Patient denies chest pain, shortness of breath or any other symptoms.  12:22 BP 132/86, p=132, rr= 18/min, o2 sat 98%RA. Patient stated that she feels like her heart is racing again and now she feels "foggy and not right". Called 9-1-1 for transport to hospital for further evaluation.  EMS arrived, assessed patient and transported patient to the hospital for further evaluation. Spouse with patient and meet patient at the hospital.
Pt. reportedly developed seizure like activity after being vaccinated by Trumenba vaccine.  Pt. had been previously vaccinated with Bexsero.
Pt developed severe urinary urgency several days after the second dose of the Moderna that has been present for 9 weeks. No prior history of this symptoms
Diarrhea,vomit,headache,high heart rate , Lasted till ten pm the following day